Document is current
Any future updates will be listed below
-
Authors
Nakayama, Kenjiro
Nemoto, Kiyotaka
Endo, Hironobu
Tagai, Kenji
Oyama, Asaka
Nemoto, Miyuki
Tamura, Masashi
Ota, Miho
Tokuda, Takahiko
Higuchi, Makoto
Arai, Tetsuaki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (25K15384)
Japan Agency for Medical Research and Development (JP24wm0625505)
Japan Agency for Medical Research and Development (JP21dk0207055, JP23wm0625001)
Japan Science and Technology Agency (JPMJCR1652, JPMJMS2024)
- License Information
-
More Information
Article History
Received: 14 March 2026
Accepted: 3 September 2026
First Online: 9 September 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Radiation Drug Safety Committee and the National Institutes for Quantum Science and Technology Certified Review Board of Japan, and the Ethics Committee of the University of Tsukuba Hospital in accordance with the Declaration of Helsinki (R02-328). Written informed consent was obtained from all participants. For participants with cognitive impairments, written informed consent was additionally obtained from their spouses or close relatives as appropriate.
Consent for publication: Not applicable.
Competing interests: M. Higuchi holds patents on compounds related to the present report (JP 5422782/EP 12 884 742.3/CA2894994/HK1208672). All other authors declare no conflict of interest.
